Mikhail S. Drenichev
Vavilova Street 32
Moscow, MOW 119991, Russian Federation
Moscow, MOW 119991, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Chiral-Modified Nucleoside Analogues: From Bioactivity to Therapeutic Applications.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 23, 2026
Validating TDP1 as an Inhibition Target for Lipophilic Nucleoside Derivative in Human Cells.
Journal: International journal of molecular sciences
Published: September 20, 2025
The Arabidopsis TIRome informs the design of artificial TIR (Toll/interleukin-1 receptor) domain proteins.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 12, 2025
Synthesis of O-Nicotinoyl-Substituted Depot Forms of Biologically Active N6-Benzyladenosine Analogs.
Synthesis of O-Nicotinoyl-Substituted Depot Forms of Biologically Active N6-Benzyladenosine Analogs.
Journal: Current protocols
Published: March 27, 2025
Preparation of 6-Azido-2-Chloropurine-2'-Deoxyriboside by Enzymatic Transglycosylation Reaction Catalyzed by Lactobacillus leichmannii Type II Nucleoside Deoxyribosyltransferase.
Journal: Doklady. Biochemistry and biophysics
Published: March 03, 2025
Substrate Specificity of E. coli Purine Nucleoside Phosphorylase in Phosphorolysis of Purine Ribonucleosides Containing a Cyclic Terpene Fragment
Journal: Molekuliarnaia biologiia
Published: February 28, 2025
N6-(5-Phenylpentan-1-yl)adenine-A New Non-competitive Receptor-Specific Anti-cytokinin.
Journal: Doklady. Biochemistry and biophysics
Published: October 15, 2023
Elongation of N6-benzyladenosine scaffold via Pd-catalyzed C-C bond formation leads to derivatives with antiflaviviral activity.
Journal: Bioorganic & medicinal chemistry
Published: September 13, 2023
Nucleoside Analog 2',3'-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1.
Journal: Pharmaceutics
Published: August 30, 2023
The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: November 12, 2022
In Planta, In Vitro and In Silico Studies of Chiral N6-Benzyladenine Derivatives: Discovery of Receptor-Specific S-Enantiomers with Cytokinin or Anticytokinin Activities.
Journal: International journal of molecular sciences
Published: August 24, 2022
Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective.
Journal: Current medicinal chemistry
Published: July 27, 2022
Last Updated: 09/26/2026